71 – 80 of 87
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
A systematic overview of radiation therapy effects in cervical cancer (cervix uteri)
(
- Contribution to journal › Article
-
Mark
A systematic overview of radiation therapy effects in non-Hodgkin's lymphoma.
(
- Contribution to journal › Article
-
Mark
A systematic overview of radiation therapy effects in brain tumours
(
- Contribution to journal › Article
-
Mark
A systematic overview of radiation therapy effects in urinary bladder cancer
(
- Contribution to journal › Article
-
Mark
Adults with GH deficiency (GHD) after acute lymphoblastic leukemia (ALL) have neuropsychological dysfunction but normal mental well-being, social interaction and -network
2003) The Endocrine Society's 85th annual meeting(
- Contribution to conference › Abstract
-
Mark
Cyklofosfamid (CP) i urin vid riskvärdering vid cytostatikaarbete
2003) Svenska Läkaresällskapets Riksstämma, 2003(
- Contribution to conference › Abstract
-
Mark
Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome
(
- Contribution to journal › Article
- 2002
-
Mark
Prognostic implications of BCL6 rearrangement in uniformly treated patients with diffuse large B-cell lymphoma--a Nordic Lymphoma Group study.
(
- Contribution to journal › Article
-
Mark
131I-labelled anti-CD22 MAb (LL2) in patients with B-cell lymphomas failing chemotherapy. Treatment outcome, haematological toxicity and bone marrow absorbed dose estimates.
(
- Contribution to journal › Article
- 2001
-
Mark
Durable response to 90-yttrium-Epratuzumab (hLL2) in B-cell lymphoma failing chemotherapy by using dose-fractionation schedule
(
- Contribution to journal › Article